(Q52597678)

4 May 2018

title

Separate mechanisms cause anemia in ischemic vs. nonischemic murine heart failure. (English)

1 reference

4 May 2018

0 references

6

Ole M Sejersted

1 reference

4 May 2018

4

Ivar Sjaastad

1 reference

4 May 2018

8

Geir Christensen

1 reference

4 May 2018

2

Kristin B Andersson

1 reference

4 May 2018

Alexandra Vanessa Finsen

3

object named as

Alexandra V Finsen

1 reference

4 May 2018

author name string

Per O Iversen

1

1 reference

4 May 2018

Thomas G von Lueder

5

1 reference

4 May 2018

Havard Attramadal

7

1 reference

4 May 2018

publication date

23 December 2009

1 reference

4 May 2018

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

published in

1 reference

4 May 2018

volume

298

1 reference

4 May 2018

issue

3

1 reference

4 May 2018

page(s)

R808-14

1 reference

4 May 2018

Guiding principles for research involving animals and human beings.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Anemia and its relationship to clinical outcome in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

The prevalence, nature, and importance of hematologic abnormalities in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Specific antibodies to mouse Sca-1- (Ly-6A/E) or Thy-1-positive haematopoietic progenitor cells induce formation of nitric oxide which inhibits subsequent colony formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Preincubation with endothelial cell monolayers increases gene transfer efficiency into human bone marrow CD34(+)CD38(-) progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Mechanisms by which exercise training benefits patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Endothelial nitric oxide synthase in vascular disease: from marvel to menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Modulation of gene expression in transgenic mouse hearts overexpressing calsequestrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Haemoglobin concentration and prognosis in new cases of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

The superoxide dismutase mimetic, tempol, reduces the bioavailability of nitric oxide and does not alter L-NAME-induced hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00250.2009

10.1152/AJPREGU.00250.2009

21 January 2018

Identifiers

DOI

1 reference

4 May 2018

1 reference

4 May 2018